作者
Neal G Haynes, Jeffrey L Lacy, Nisha Nayak, Chris S Martin, Dayang Dai, Carla J Mathias, Mark A Green
发表日期
2000/2/1
期刊
Journal of Nuclear Medicine
卷号
41
期号
2
页码范围
309-314
出版商
Society of Nuclear Medicine
简介
NaOAc) and 1 mL ligandsolution (2 ppm PTSM, 2% EtOH) passingftthroughaseptumintoa35-ccsyringepr@ oadedwfth28mL stenlewater. This solutionis thoroughlymixed by agitationof the syringeandinjectedasabolusthrougha0. 2pmfilter. Thegenerator is eluted twice before shipping, providing quality assurance samples, and shipped to the clinical site by overnight delivery. Complete quality assurance testing is performed the evening before the generator reaches the clinical site. Results: A total of 34 generatorshavebeenproducedandshippedto2clinicalsitesfor a phase Ill Food and DrugAdministrationstudy. The load activity on the generatorsat 8: 00 AMthe day of dinical usewas 1.7 ±0.2 GBq (46.7 ±5.6 mCi), and yield was 72% ±16%. Breakthrough of e2Zn was undetectable by high-purity germanium spectroscopy for all units. Radiochemical purity was 95.4% ±2.4%. Volume delivered, pH, sterility, and bacterial …
引用总数
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202322234977476744743254521
学术搜索中的文章